Novel therapeutic choices in immune aplastic anemia [version 1; peer review: 2 approved]
Aplastic anemia (AA) in its severe form has historically been associated with high mortality. With limited supportive care and no effective strategy to reverse marrow failure, most patients diagnosed with severe AA (SAA) died of pancytopenia complications. Since the 1970s, hematopoietic stem cell tr...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2020-09-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/9-1118/v1 |